Kunming Longjin Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002750.SZ

Kunming Longjin Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2023: -11.23%

Kunming Longjin Pharmaceutical Co., Ltd. Return on Assets (ROA) is -11.23% for the year ending December 31, 2023, a -14.13% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Kunming Longjin Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2022 was -9.84%, a -991.24% change year over year.
Kunming Longjin Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2021 was -0.90%, a -197.89% change year over year.
Kunming Longjin Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2020 was 0.92%, a 131.05% change year over year.
Kunming Longjin Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2019 was -2.97%, a -268.44% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

Shenzhen Stock Exchange: 002750.SZ

Kunming Longjin Pharmaceutical Co., Ltd.

CEO	Mr. Ya He Li
IPO Date	March 24, 2015
Location	China
Headquarters	NO.789, Lanmao Road
Employees	285
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies Non-Alcoholic Beverages Personal Care Pet Food Plastics

Description

Kunmig Longjin Pharmaceutical Co., Ltd. develops, produces, and sells natural botanicals and chemical freeze-dried powder injections in China. The company offers Chinese, biochemical, chemical, cardio-cerebral vascular, and digestive system medicines; immune system and first aid medications; and vitamins, minerals, and enteral and parenteral nutrition products. It also engages in the industrial hemp plantation business. The company was founded in 1996 and is headquartered in Kunming, China.

Key trends

Past 5 years